Search - tctmd.com

Displaying 261 - 280 of 541

Sort: Relevancy | Date

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presentation TVT 2021

Percutaneous Left Atrial Appendage Closure Versus Oral Anticoagulation for Non-Valvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Yousif Ahmad

July 22, 2021

Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices

Presentation TVT 2021

Implications of COVID-19 Related Reductions of HF Hospitalizations on Clinical Trials of HF Devices

Presenter: JoAnn Lindenfeld

July 22, 2021

How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices

Presentation TVT 2021

How Changes in GDMT for HF Are Impacting Clinical Trials of HF Devices

Presenter: Susan M. Joseph

July 22, 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

News Conference News TVT 2021

Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market

July 22, 2021

#TAVR Case Reports on Twitter Paint Overly Optimistic Picture

News Daily News

#TAVR Case Reports on Twitter Paint Rosy Picture

July 21, 2021

TMVR Patient Eligibility and Clinical Trial Considerations in the Post-COAPT Era (MVARC II)

Presentation TVT 2021

TMVR Patient Eligibility and Clinical Trial Considerations in the Post-COAPT Era (MVARC II)

Presenter: Gregg Stone

July 21, 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presentation TVT 2021

Cerebral Embolic Protection: Updates From the Clinical Trials and Future Directions

Presenter: Samir Kapadia

July 21, 2021

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Presentation TVT 2021

First Report of 2-Year Outcomes With a Next-Generation Left Atrial Appendage Closure Device: Final Results From the PINNACLE FLX IDE Trial

Presenter: Saibal Kar

July 21, 2021

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

News Daily News

Myocarditis and COVID-19 Vaccines: New Review Tackles Knowns, Unknowns

July 20, 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

News Conference News TVT 2021

TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year

July 20, 2021

Clinical Trial Considerations for Bicuspid Aortic Valve for Disease: What Should the Next Study Look Like?

Presentation TVT 2021

Clinical Trial Considerations for Bicuspid Aortic Valve for Disease: What Should the Next Study Look Like?

Presenter: David Cohen

July 20, 2021

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

News Conference News SCCT 2021

As New Guidelines Loom, CT Community Seeks to Fill Knowledge Gaps

Yael L. Maxwell

July 20, 2021

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Presentation TVT 2021

Rehospitalization and Mortality in Patients With Heart Failure and Secondary Severe Mitral Regurgitation: The COAPT Trial

Presenter: Gennaro Giustino

July 20, 2021

Predictors of Reduction in Mitral Regurgitation by the MitraClip - Durable, Transient, or Failures in the COAPT Trial

Presentation TVT 2021

Predictors of Reduction in Mitral Regurgitation by the MitraClip - Durable, Transient, or Failures in the COAPT Trial

Presenter: Scott Lim

July 20, 2021

Apixaban May Be Best DOAC for Frail, Older Patients With AF

News Daily News

Apixaban May Be Best DOAC for Frail, Older Patients With AF

July 19, 2021

Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest

News Daily News

Acute MI More Common After TAVI vs SAVR, Real-World Data Suggest

July 19, 2021

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

News Daily News

De-escalation Tops Other DAPT Tactics for ACS: Meta-analysis

Yael L. Maxwell

July 16, 2021

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

News Daily News

Latest Statin Risk-Benefit Analysis: More Harm Than Good?

Yael L. Maxwell

July 15, 2021

DOACs May Have Advantage Over VKAs After TAVI, Study Hints

News Daily News

DOACs May Have Advantage Over VKAs After TAVI, Study Hints

July 14, 2021

Statin Effects in Nonobstructive CAD Hinge on Plaque Burden, Coronary CTA Reveals

News Daily News

Statin Effects in Nonobstructive CAD Hinge on Plaque Burden, CTA Reveals

July 14, 2021

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.